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Objective
To assess the efficacy of IL-1 beta receptor antagonist (IL-
1RA) in the treatment of steroid dependent idiopathic
recurrent pericarditis (RP).
Methods
Three patients (1 male, 2 females, aged between 13 and
16) were enrolled. RP was defined by "pericardial" pain
and ≥1 of the following signs: fever, pericardial friction
rub, electrocardiographic changes, echocardiographic evi-
dence of pericardial effusion, elevated acute phase reac-
tants.
Patients showed recurrent flares of pericarditis with
malaise, precordial pain, tachyorthopnoea, sometimes
fever. 2/3 developed a life-threatening cardiac tamponade
needing pericardiotomy. None of them presented signs or
symptoms consistent with a chronic rheumatic disease:
antinuclear, anti-coxsackie and anti adenovirus antibod-
ies were negative. Genetic analysis ruled out Familial
Mediterranean Fever. Mean disease duration was 2 years
and mean rate of recurrences was 4 yearly. Pericarditis
seemed steroid dependent and poorly responsive to col-
chicine.
Results
IL-1RA administration was associated with a dramatic dis-
appearance of symptoms and normalization of acute
phase reactants. In all three patients IL-1RA was stopped
after the achievement of a complete remission. In all
cases, withdrawal was followed by a flare after a few
weeks. The reinstitution of IL-1RA was associated with a
new immediate response. All patients were mantained on
IL-1RA treatment whilst steroids were tapered and
stopped; at a mean follow-up of 4 months, none of them
has experienced a disease relapse.
Conclusion
IL1-RA may be effective in the treatment of idiopathic
recurrent pericarditis; moreover, this preliminary finding
seems to suggest that these patients could be affected by a
new, not yet identified, genetic autoinflammatory disease.
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